Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 (-)Deprenyl in the treatment of Parkinson's disease.

× No keyword cloud information.

15 in total

Review 1. Selegiline and Parkinson's disease. Protective and symptomatic considerations.

Authors: L I Golbe; J W Langston; I Shoulson
Journal: Drugs Date: 1990-05 Impact factor: 9.546

Review 2. Parkinson's disease.

Authors: E C Wolters; D B Calne
Journal: CMAJ Date: 1989-03-01 Impact factor: 8.262

Review 3. Monoamine oxidase inhibitors revisited.

Authors: D G Wells; A R Bjorksten
Journal: Can J Anaesth Date: 1989-01 Impact factor: 5.063

Review 4. Economic and health-related quality of life considerations of new therapies in Parkinson's disease.

Authors: L M Rubenstein; A DeLeo; E A Chrischilles
Journal: Pharmacoeconomics Date: 2001 Impact factor: 4.981

Review 5. Parkinson's disease in 1984: an update.

Authors: A E Lang; R D Blair
Journal: Can Med Assoc J Date: 1984-11-01 Impact factor: 8.262

Review 6. The effect of L-deprenyl on behavior, cognitive function, and biogenic amines in the dog.

Authors: N W Milgram; G O Ivy; E Head; M P Murphy; P H Wu; W W Ruehl; P H Yu; D A Durden; B A Davis; I A Paterson
Journal: Neurochem Res Date: 1993-12 Impact factor: 3.996

Review 7. Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition.

Authors: M B Youdim; P Riederer
Journal: J Neural Transm Gen Sect Date: 1993

8. Tyramine pressor sensitivity changes during deprenyl treatment.

Authors: T Sunderland; E A Mueller; R M Cohen; D C Jimerson; D Pickar; D L Murphy
Journal: Psychopharmacology (Berl) Date: 1985 Impact factor: 4.530

9. The neuropharmacological profile of N-methyl-N-propargyl-2-aminotetralin: a potent monoamine oxidase inhibitor.

Authors: B Hazelhoff; J B De Vries; D Dijkstra; W de Jong; A S Horn
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1985-07 Impact factor: 3.000

10. Different roles for type A and type B monoamine oxidase in regulating synaptic dopamine at D-1 and D-2 receptors associated with adenosine-3',5'-cyclic monophosphate (cyclic AMP) formation.

Authors: J Liccione; A J Azzaro
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1988-02 Impact factor: 3.000